Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma.

Transl Oncol · 2025 · PMC11787715 · PMID 39837057

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Statistical significance was determined at a threshold of p < 0.05, with p < 0.01 representing a highly significant difference.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.